Yahoo Web Search

    • Why Investors Didn't Like Lilly's Q1 Results

      Why Investors Didn't Like Lilly's Q1 Results

      Motley Fool· 6 months ago

      Eli Lilly (NYSE: LLY) has delivered quite a bit of bad news in recent weeks. The U.S. Food and Drug Administration (FDA) delayed its review of Lilly's...